Clene, Inc.

As of June 20, 2025, the market trend is neutral with mixed signals: weekly indicators show mild bullishness, while daily trends and monthly perspectives lean bearish, indicating a weak overall trend with no clear direction.

Clene, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $1 million as of March 2025, with a market cap of $38 million. Key metrics include a negative P/E ratio and a return on equity of 618.92%.

As of Jun 18, Clene, Inc. has a market capitalization of 38.00 million, with net sales of 0.35 million and a net profit of -29.08 million over the last four quarters. As of Dec 24, shareholder's funds are at -8.86 million, and total assets are 27.34 million.